Pharmaceutical attention and risks of polypharmacy in elderly people: an integrative literature review

Detalhes bibliográficos
Autor(a) principal: Noleto, Ana Lucia dos Santos
Data de Publicação: 2021
Outros Autores: Melo, Jose Douglas da Gama, Moura, Maria da Paz Dias Costa, Marquez, Carolinne de Oliveira
Tipo de documento: Artigo
Idioma: por
eng
Título da fonte: Scire Salutis
DOI: 10.6008/CBPC2236-9600.2022.001.0030
Texto Completo: https://sustenere.inf.br/index.php/sciresalutis/article/view/6166
Resumo: The use of medications is today an epidemic among the elderly, whose occurrence is set in the exponential increase in the prevalence of chronic diseases and the sequelae that accompany advancing age. Studies have shown that pharmaceutical intervention through educational actions and guidance on the therapeutic regimen brings benefits to the patient's health and to the health promotion process. To investigate the efficiency of pharmaceutical care in relation to the potential risks of polypharmacy in the elderly. The search for studies was carried out in the NCBI/PubMed (National Center for Biotechnology Information), SciELO (Scientific Electronic Lirary Online), GGA (Geriatrics, Gerontology and Aging) and Lilacs - Bireme (Latin Literature) databases. American and Caribbean in Health Sciences). The following inclusion criteria were established: articles available in full, in Portuguese and English, from 2000 to 2021, with free access and that had an affinity with the subject. In the end, 15 studies were included to integrate this review article. From these studies, we emphasize the multiplicity of diseases and drugs associated with changes related to aging, triggering serious drug interactions and adverse reactions in the elderly. Medication-related errors are a public health problem, it is necessary to be aware that the pharmacist is a health agent, responsible for offering reliable technical guidance on medication, based on the extensive knowledge of this class of professionals.
id ESS-1_3808c1ce366a00dcd5a531b6252d60cc
oai_identifier_str oai:ojs.pkp.sfu.ca:article/6166
network_acronym_str ESS-1
network_name_str Scire Salutis
spelling Pharmaceutical attention and risks of polypharmacy in elderly people: an integrative literature reviewAtenção farmacêutica e os riscos da polifarmácia em idosos: uma revisão integrativa de literaturaIdosoPolifarmáciaAtenção FarmacêuticaElderlyPolypharmacyPharmaceutical CareThe use of medications is today an epidemic among the elderly, whose occurrence is set in the exponential increase in the prevalence of chronic diseases and the sequelae that accompany advancing age. Studies have shown that pharmaceutical intervention through educational actions and guidance on the therapeutic regimen brings benefits to the patient's health and to the health promotion process. To investigate the efficiency of pharmaceutical care in relation to the potential risks of polypharmacy in the elderly. The search for studies was carried out in the NCBI/PubMed (National Center for Biotechnology Information), SciELO (Scientific Electronic Lirary Online), GGA (Geriatrics, Gerontology and Aging) and Lilacs - Bireme (Latin Literature) databases. American and Caribbean in Health Sciences). The following inclusion criteria were established: articles available in full, in Portuguese and English, from 2000 to 2021, with free access and that had an affinity with the subject. In the end, 15 studies were included to integrate this review article. From these studies, we emphasize the multiplicity of diseases and drugs associated with changes related to aging, triggering serious drug interactions and adverse reactions in the elderly. Medication-related errors are a public health problem, it is necessary to be aware that the pharmacist is a health agent, responsible for offering reliable technical guidance on medication, based on the extensive knowledge of this class of professionals.O uso de medicamentos constitui-se hoje uma epidemia entre idosos, cuja ocorrência tem como cenário o aumento exponencial da prevalência de doenças crônicas e das sequelas que acompanham o avançar da idade. Estudos têm mostrado que a intervenção farmacêutica por meio de ações educativas e orientações sobre o regime terapêutico traz benefícios à saúde do paciente e ao processo de promoção da saúde. Investigar a eficiência da atenção farmacêutica em relação aos potenciais riscos da polifarmácia em idosos. A busca de estudos realizou-se nas bases de dados NCBI/PubMed (National Center for Biotechnology Information), SciELO (Scientific Eletronic Lirary Online), GGA (Geriatrics, Gerontology and Aging) e Lilacs - Bireme (Literatura Latino-Americana e do Caribe em Ciências da Saúde). Estabeleceram-se os seguintes critérios de inclusão: artigos disponíveis na integra, em português e inglês, no período de 2000 a 2021 com acesso gratuito e que tivessem afinidade com a temática. Ao final, foram incluídos 15 estudos para integrar este artigo de revisão. A partir desses estudos ressaltamos a multiplicidade de doenças e de fármacos associada a alterações relacionadas ao envelhecimento, desencadeando graves interações medicamentosas e reações adversas nos idosos. Os erros relacionados a medicamentos são um problema de saúde pública, é preciso a conscientização de que o profissional farmacêutico é um agente da saúde, responsável por ofertar orientações técnicas de confiança sobre medicamentos, baseado no amplo conhecimento dessa classe de profissionais.Sustenere Publishing2021-09-28info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://sustenere.inf.br/index.php/sciresalutis/article/view/616610.6008/CBPC2236-9600.2022.001.0030Scire Salutis; Vol. 12 No. 1 (2022): Scire Salutis - Out, Nov, Dez 2021, Jan 2022; 270-278Scire Salutis; Vol. 12 Núm. 1 (2022): Scire Salutis - Out, Nov, Dez 2021, Jan 2022; 270-278Scire Salutis; v. 12 n. 1 (2022): Scire Salutis - Out, Nov, Dez 2021, Jan 2022; 270-2782236-9600reponame:Scire Salutisinstname:Companhia Brasileira de Produção Científica (CBPC)instacron:ESSporenghttps://sustenere.inf.br/index.php/sciresalutis/article/view/6166/3511https://sustenere.inf.br/index.php/sciresalutis/article/view/6166/3510Copyright (c) 2022 Scire Salutishttp://creativecommons.org/licenses/by-nc-nd/4.0info:eu-repo/semantics/openAccessNoleto, Ana Lucia dos SantosMelo, Jose Douglas da GamaMoura, Maria da Paz Dias CostaMarquez, Carolinne de Oliveira2023-01-04T20:16:22Zoai:ojs.pkp.sfu.ca:article/6166Revistahttps://sustenere.co/index.php/sciresalutisONGhttps://sustenere.co/index.php/sciresalutis/oai||carlos@arvore.org.br2236-96002236-9600opendoar:2023-01-04T20:16:22Scire Salutis - Companhia Brasileira de Produção Científica (CBPC)false
dc.title.none.fl_str_mv Pharmaceutical attention and risks of polypharmacy in elderly people: an integrative literature review
Atenção farmacêutica e os riscos da polifarmácia em idosos: uma revisão integrativa de literatura
title Pharmaceutical attention and risks of polypharmacy in elderly people: an integrative literature review
spellingShingle Pharmaceutical attention and risks of polypharmacy in elderly people: an integrative literature review
Pharmaceutical attention and risks of polypharmacy in elderly people: an integrative literature review
Noleto, Ana Lucia dos Santos
Idoso
Polifarmácia
Atenção Farmacêutica
Elderly
Polypharmacy
Pharmaceutical Care
Noleto, Ana Lucia dos Santos
Idoso
Polifarmácia
Atenção Farmacêutica
Elderly
Polypharmacy
Pharmaceutical Care
title_short Pharmaceutical attention and risks of polypharmacy in elderly people: an integrative literature review
title_full Pharmaceutical attention and risks of polypharmacy in elderly people: an integrative literature review
title_fullStr Pharmaceutical attention and risks of polypharmacy in elderly people: an integrative literature review
Pharmaceutical attention and risks of polypharmacy in elderly people: an integrative literature review
title_full_unstemmed Pharmaceutical attention and risks of polypharmacy in elderly people: an integrative literature review
Pharmaceutical attention and risks of polypharmacy in elderly people: an integrative literature review
title_sort Pharmaceutical attention and risks of polypharmacy in elderly people: an integrative literature review
author Noleto, Ana Lucia dos Santos
author_facet Noleto, Ana Lucia dos Santos
Noleto, Ana Lucia dos Santos
Melo, Jose Douglas da Gama
Moura, Maria da Paz Dias Costa
Marquez, Carolinne de Oliveira
Melo, Jose Douglas da Gama
Moura, Maria da Paz Dias Costa
Marquez, Carolinne de Oliveira
author_role author
author2 Melo, Jose Douglas da Gama
Moura, Maria da Paz Dias Costa
Marquez, Carolinne de Oliveira
author2_role author
author
author
dc.contributor.author.fl_str_mv Noleto, Ana Lucia dos Santos
Melo, Jose Douglas da Gama
Moura, Maria da Paz Dias Costa
Marquez, Carolinne de Oliveira
dc.subject.por.fl_str_mv Idoso
Polifarmácia
Atenção Farmacêutica
Elderly
Polypharmacy
Pharmaceutical Care
topic Idoso
Polifarmácia
Atenção Farmacêutica
Elderly
Polypharmacy
Pharmaceutical Care
description The use of medications is today an epidemic among the elderly, whose occurrence is set in the exponential increase in the prevalence of chronic diseases and the sequelae that accompany advancing age. Studies have shown that pharmaceutical intervention through educational actions and guidance on the therapeutic regimen brings benefits to the patient's health and to the health promotion process. To investigate the efficiency of pharmaceutical care in relation to the potential risks of polypharmacy in the elderly. The search for studies was carried out in the NCBI/PubMed (National Center for Biotechnology Information), SciELO (Scientific Electronic Lirary Online), GGA (Geriatrics, Gerontology and Aging) and Lilacs - Bireme (Latin Literature) databases. American and Caribbean in Health Sciences). The following inclusion criteria were established: articles available in full, in Portuguese and English, from 2000 to 2021, with free access and that had an affinity with the subject. In the end, 15 studies were included to integrate this review article. From these studies, we emphasize the multiplicity of diseases and drugs associated with changes related to aging, triggering serious drug interactions and adverse reactions in the elderly. Medication-related errors are a public health problem, it is necessary to be aware that the pharmacist is a health agent, responsible for offering reliable technical guidance on medication, based on the extensive knowledge of this class of professionals.
publishDate 2021
dc.date.none.fl_str_mv 2021-09-28
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://sustenere.inf.br/index.php/sciresalutis/article/view/6166
10.6008/CBPC2236-9600.2022.001.0030
url https://sustenere.inf.br/index.php/sciresalutis/article/view/6166
identifier_str_mv 10.6008/CBPC2236-9600.2022.001.0030
dc.language.iso.fl_str_mv por
eng
language por
eng
dc.relation.none.fl_str_mv https://sustenere.inf.br/index.php/sciresalutis/article/view/6166/3511
https://sustenere.inf.br/index.php/sciresalutis/article/view/6166/3510
dc.rights.driver.fl_str_mv Copyright (c) 2022 Scire Salutis
http://creativecommons.org/licenses/by-nc-nd/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2022 Scire Salutis
http://creativecommons.org/licenses/by-nc-nd/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Sustenere Publishing
publisher.none.fl_str_mv Sustenere Publishing
dc.source.none.fl_str_mv Scire Salutis; Vol. 12 No. 1 (2022): Scire Salutis - Out, Nov, Dez 2021, Jan 2022; 270-278
Scire Salutis; Vol. 12 Núm. 1 (2022): Scire Salutis - Out, Nov, Dez 2021, Jan 2022; 270-278
Scire Salutis; v. 12 n. 1 (2022): Scire Salutis - Out, Nov, Dez 2021, Jan 2022; 270-278
2236-9600
reponame:Scire Salutis
instname:Companhia Brasileira de Produção Científica (CBPC)
instacron:ESS
instname_str Companhia Brasileira de Produção Científica (CBPC)
instacron_str ESS
institution ESS
reponame_str Scire Salutis
collection Scire Salutis
repository.name.fl_str_mv Scire Salutis - Companhia Brasileira de Produção Científica (CBPC)
repository.mail.fl_str_mv ||carlos@arvore.org.br
_version_ 1822179460392157184
dc.identifier.doi.none.fl_str_mv 10.6008/CBPC2236-9600.2022.001.0030

Registros relacionados